E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/24/2021 in the Prospect News Structured Products Daily.

New Issue: Barclays sells $364,000 trigger autocallable contingent yield notes on Jazz Pharmaceuticals

By Wendy Van Sickle

Columbus, Ohio, May 24 – Barclays Bank plc priced $364,000 of trigger autocallable contingent yield notes due May 3, 2024 linked to the common shares of Jazz Pharmaceuticals plc according to a 424B2 filing with the Securities and Exchange Commission.

Each quarter, the notes will pay a contingent coupon at the rate of 8% per year if the shares close at or above the downside threshold level, 63.7% of the initial share price, on the observation date for that quarter.

The notes will be automatically called at par if shares close at or above the initial share price on any quarterly observation date after six months.

If the notes are not called and the final share price is greater than or equal to the threshold level, the payout at maturity will be par. Otherwise, investors will be fully exposed to the decline of the stock from its initial level.

UBS Financial Services Inc. and Barclays Capital Inc. are the agents.

Issuer:Barclays Bank plc
Issue:Trigger autocallable contingent yield notes
Underlying stock:Jazz Pharmaceuticals plc
Amount:$364,000
Maturity:May 3, 2024
Contingent coupon:8%, payable quarterly if stock closes at or above downside threshold on observation date for that quarter
Price:Par
Payout at maturity:Par unless stock finishes below downside threshold level, in which case exposure to all losses
Call:At par if stock closes at or above initial level on any quarterly observation date after six months
Initial price:$164.40
Downside threshold:$104.72, 63.7% of initial price
Pricing date:April 30
Settlement date:May 5
Agents:UBS Financial Services Inc. and Barclays Capital Inc.
Fees:2%
Cusip:06747R121

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.